stella
beta
Dose Escalation Pilot Study to Evaluate the Safety of Alocyte for the Treatment of Facetogenic Back Pain — Stella
Recruiting
Back to Facet Joints; Degeneration trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
The Center for Regenerative Medicine, North Miami, Florida
View full record on ClinicalTrials.gov